Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 1
2005 1
2007 2
2008 1
2009 2
2010 2
2011 3
2012 3
2013 6
2014 7
2015 5
2016 4
2017 8
2018 5
2019 8
2020 8
2021 3
2022 12
2023 6
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Results by year

Filters applied: . Clear all
Page 1
Ceftazidime-Avibactam plus Aztreonam for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria.
Sempere A, Viñado B, Los-Arcos I, Campany D, Larrosa N, Fernández-Hidalgo N, Rodríguez-Pardo D, González-López JJ, Nuvials X, Almirante B, Escolà-Vergé L. Sempere A, et al. Among authors: larrosa n. Antimicrob Agents Chemother. 2022 Oct 18;66(10):e0075122. doi: 10.1128/aac.00751-22. Epub 2022 Sep 14. Antimicrob Agents Chemother. 2022. PMID: 36102635 Free PMC article.
Executive summary of the consensus document of the Spanish Society of Infectious Diseases and Clinical Microbiology (SEIMC) on the diagnosis and antimicrobial treatment of infections due to carbapenem-resistant Gram-negative bacteria.
Pintado V, Ruiz-Garbajosa P, Aguilera-Alonso D, Baquero-Artigao F, Bou G, Cantón R, Grau S, Gutiérrez-Gutiérrez B, Larrosa N, Machuca I, Martínez Martínez L, Montero MM, Morte-Romea E, Oliver A, Paño-Pardo JR, Sorlí L. Pintado V, et al. Among authors: larrosa n. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Jun-Jul;41(6):360-370. doi: 10.1016/j.eimce.2022.06.014. Epub 2022 Dec 13. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36522272
Justification for 24/7 clinical microbiology services.
Bou G, Calbo E, Crespo M, Cantón R, Álvarez de Luna FF, García Rodríguez J, Ángel Goenaga M, González-García J, Gonzàlez J, Larrosa N, Martínez-Martínez L, Navarro D, Ramón Paño J, Rivero A, Carlos Rodríguez J, Tomás M, Vilaj J. Bou G, et al. Among authors: larrosa n. Enferm Infecc Microbiol Clin (Engl Ed). 2022 Jan;40(1):1-4. doi: 10.1016/j.eimce.2021.08.014. Enferm Infecc Microbiol Clin (Engl Ed). 2022. PMID: 34991847 No abstract available.
Antimicrobial stewardship in hospitals: Expert recommendation guidance document for activities in specific populations, syndromes and other aspects (PROA-2) from SEIMC, SEFH, SEMPSPGS, SEMICYUC and SEIP.
Cercenado E, Rodríguez-Baño J, Alfonso JL, Calbo E, Escosa L, Fernández-Polo A, García-Rodríguez J, Garnacho J, Gil-Navarro MV, Grau S, Gudiol C, Horcajada JP, Larrosa N, Martínez C, Molina J, Nuvials X, Oliver A, Paño-Pardo JR, Pérez-Rodríguez MT, Ramírez P, Rey-Biel P, Vidal P, Retamar-Gentil P. Cercenado E, et al. Among authors: larrosa n. Enferm Infecc Microbiol Clin (Engl Ed). 2023 Apr;41(4):238-242. doi: 10.1016/j.eimce.2022.05.013. Epub 2023 Jan 5. Enferm Infecc Microbiol Clin (Engl Ed). 2023. PMID: 36610836 Review.
Pseudomonas aeruginosa antibiotic susceptibility profiles, genomic epidemiology and resistance mechanisms: a nation-wide five-year time lapse analysis.
Sastre-Femenia MÀ, Fernández-Muñoz A, Gomis-Font MA, Taltavull B, López-Causapé C, Arca-Suárez J, Martínez-Martínez L, Cantón R, Larrosa N, Oteo-Iglesias J, Zamorano L, Oliver A; GEMARA-SEIMC/CIBERINFEC Pseudomonas study Group. Sastre-Femenia MÀ, et al. Among authors: larrosa n. Lancet Reg Health Eur. 2023 Sep 19;34:100736. doi: 10.1016/j.lanepe.2023.100736. eCollection 2023 Nov. Lancet Reg Health Eur. 2023. PMID: 37753216 Free PMC article.
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study.
Gutiérrez-Gutiérrez B, Salamanca E, de Cueto M, Hsueh PR, Viale P, Paño-Pardo JR, Venditti M, Tumbarello M, Daikos G, Cantón R, Doi Y, Tuon FF, Karaiskos I, Pérez-Nadales E, Schwaber MJ, Azap ÖK, Souli M, Roilides E, Pournaras S, Akova M, Pérez F, Bermejo J, Oliver A, Almela M, Lowman W, Almirante B, Bonomo RA, Carmeli Y, Paterson DL, Pascual A, Rodríguez-Baño J; REIPI/ESGBIS/INCREMENT Investigators. Gutiérrez-Gutiérrez B, et al. Lancet Infect Dis. 2017 Jul;17(7):726-734. doi: 10.1016/S1473-3099(17)30228-1. Epub 2017 Apr 22. Lancet Infect Dis. 2017. PMID: 28442293
Current perspectives in the management of sepsis and septic shock.
Chiscano-Camón L, Ruiz-Sanmartin A, Bajaña I, Bastidas J, Lopez-Martinez R, Franco-Jarava C, Gonzalez JJ, Larrosa N, Riera J, Nuvials-Casals X, Ruiz-Rodríguez JC, Ferrer R. Chiscano-Camón L, et al. Among authors: larrosa n. Front Med (Lausanne). 2024 Aug 15;11:1431791. doi: 10.3389/fmed.2024.1431791. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39211340 Free PMC article. Review.
Precision medicine in sepsis and septic shock: From omics to clinical tools.
Ruiz-Rodriguez JC, Plata-Menchaca EP, Chiscano-Camón L, Ruiz-Sanmartin A, Pérez-Carrasco M, Palmada C, Ribas V, Martínez-Gallo M, Hernández-González M, Gonzalez-Lopez JJ, Larrosa N, Ferrer R. Ruiz-Rodriguez JC, et al. Among authors: larrosa n. World J Crit Care Med. 2022 Jan 9;11(1):1-21. doi: 10.5492/wjccm.v11.i1.1. eCollection 2022 Jan 9. World J Crit Care Med. 2022. PMID: 35433311 Free PMC article. Review.
In vitro activity of cefiderocol against European Pseudomonas aeruginosa and Acinetobacter spp., including isolates resistant to meropenem and recent β-lactam/β-lactamase inhibitor combinations.
Santerre Henriksen A, Jeannot K, Oliver A, Perry JD, Pletz MW, Stefani S, Morrissey I, Longshaw C; ARTEMIS Study Investigators. Santerre Henriksen A, et al. Microbiol Spectr. 2024 Apr 2;12(4):e0383623. doi: 10.1128/spectrum.03836-23. Epub 2024 Mar 14. Microbiol Spectr. 2024. PMID: 38483164 Free PMC article.
Catastrophic Streptococcus pyogenes Disease: A Personalized Approach Based on Phenotypes and Treatable Traits.
Ruiz-Rodríguez JC, Chiscano-Camón L, Maldonado C, Ruiz-Sanmartin A, Martin L, Bajaña I, Bastidas J, Lopez-Martinez R, Franco-Jarava C, González-López JJ, Ribas V, Larrosa N, Riera J, Nuvials-Casals X, Ferrer R. Ruiz-Rodríguez JC, et al. Among authors: larrosa n. Antibiotics (Basel). 2024 Feb 15;13(2):187. doi: 10.3390/antibiotics13020187. Antibiotics (Basel). 2024. PMID: 38391573 Free PMC article.
77 results